FinTechFunding

Antisense Therapeutics: Shares rise on long COVID-19 study

Antisense Therapeutics Shares rise on long COVID-19 study

  • Antisense Therapeutics (ANP) announces the outcomes of its collaboration to study the neurological aspects of long COVID-19 in patients who hadn’t been hospitalised
  • Blood samples were collected and used to generate data on up to 7000 proteins in the blood using the proteomics protein analysis
  • Data identified a number of proteins that can be used as diagnostic markers which could help identify neuro long COVID patients for better designed clinical trials
  • Antisense plans to review new patent applications in the US with targeted pharmaceutical and diagnostic companies for potential commercial discussions
  • ANP shares are up 18.2 per cent on the market to trade at 13 cents as of 1:42 pm AEST
Previous article
X2M Connect: Completes $3.97m entitlement offer
Next article
Meson: Raises $4M in Funding
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

Scammers Impersonate NAB Trade’s Tom Piotrowski to Endorse Fraudulent Investments

NAB Trade warns investors about the ongoing impersonation scams targeting clients.Highlights: Scammers are impersonating Tom Piotrowski from NAB...
FinTech

Bermuda Strengthens Onchain Economy with New Regulatory Framework

Government seeks to attract blockchain innovation and investment.Highlights: Bermuda introduces new regulations to boost its onchain economy.The framework...
FinTech

Australia Tightens Cash Acceptance Rules for Retailers

New regulations will impact how retailers handle cash transactions.Highlights: Australia introduces stricter cash acceptance rules for retailers.The new...
FinTech

Trump Calls on Congress to Cap Credit Card Rates

The former president urges lawmakers to limit high interest rates amid economic concerns.Highlights: Trump advocates for capping credit...

Follow us

Daily fintech insights, global payment trends, and industry moves that matter. Because in finance, timing is everything.

Company

Latest News

Scammers Impersonate NAB Trade’s Tom Piotrowski to Endorse Fraudulent Investments

FinTech 0
NAB Trade warns investors about the ongoing impersonation scams...

Bermuda Strengthens Onchain Economy with New Regulatory Framework

FinTech 0
Government seeks to attract blockchain innovation and investment.Highlights: Bermuda...

Australia Tightens Cash Acceptance Rules for Retailers

FinTech 0
New regulations will impact how retailers handle cash transactions.Highlights:...

Popular News

Scammers Impersonate NAB Trade’s Tom Piotrowski to Endorse Fraudulent Investments

FinTech 0
NAB Trade warns investors about the ongoing impersonation scams...

Bermuda Strengthens Onchain Economy with New Regulatory Framework

FinTech 0
Government seeks to attract blockchain innovation and investment.Highlights: Bermuda...

Australia Tightens Cash Acceptance Rules for Retailers

FinTech 0
New regulations will impact how retailers handle cash transactions.Highlights:...

© 2026 FintechInshorts. All Rights Reserved.